Morbidity of the Donor Site and Complication Rates of Breast Reconstruction with Autologous Abdominal Flaps: A Systematic Review and Meta-Analysis
Table 2
Descriptive data of the number of complications (events) and total number of patients as well as the outcomes of heterogeneity and inconsistency analyses.
Outcome
k
Events/total
Within designs (heterogeneity)
Between designs (inconsistency)
Consistency¥
DIEP
FTRAM
PTRAM
SEIA
Q
Q
Q
Donor hernia/bulge
18
115/4726
247/4554
218/2773
0/154
17.01
0.149
24.19
0.002
41.20
0.004
Donor wound infection
4
191/3991
155/2635
188/2589
9/71
NA
NA
4.43
0.351
4.43
0.351
Flap fat necrosis
19
253/1679
414/2454
137/596
25/228
88.07
<0.0001
11.94
0.102
1.60
0.979
Mastectomy flap necrosis
7
47/663
53/1107
15/158
7/140
2.05
0.562
1.52
0.678
1.52
0.678
Flap hematoma
13
624/15452
250/9008
150/7639
45/549
47.49
<0.0001
35.21
<0.0001
12.51
0.028
Flap total thrombotic event
4
2124/8312
146/7171
NA
50/410
NA
NA
15.32
0.002
15.32
0.002
Partial flap loss
12
166/7390
351/6330
68/5581
6/385
43.94
<0.0001
14.85
0.005
0.22
0.994
Total flap loss
14
133/7493
63/6310
44/5606
8/395
15.37
0.119
12.70
0.048
6.60
0.359
Flap wound infection
8
41/891
33/908
28/380
5/150
1.88
0.598
2.48
0.779
2.48
0.778
The number of studies in each comparison; consistency under the assumption of a full design-by-treatment interaction random-effects model.
